Similar articles for PMID: 11750877

Year	Number of Results
1999	2
2000	11
2001	15
2002	13
2003	17
2004	19
2005	14
2006	11
2007	2
2008	4
2009	2
2010	3
2011	5
2012	4
2013	4
2014	1
2015	1
2016	1
2021	1
2023	1
2024	0

1

Mechanism of BLyS action in B cell immunity.

Do RK, Chen-Kiang S. Do RK, et al. Cytokine Growth Factor Rev. 2002 Feb;13(1):19-25. doi: 10.1016/s1359-6101(01)00025-9. Cytokine Growth Factor Rev. 2002. PMID: 11750877 Review.

2

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.

Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S, Cancro M, Grewal IS, Dixit VM. Yan M, et al. Curr Biol. 2001 Oct 2;11(19):1547-52. doi: 10.1016/s0960-9822(01)00481-x. Curr Biol. 2001. PMID: 11591325 Free article.

3

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH. Gross JA, et al. Nature. 2000 Apr 27;404(6781):995-9. doi: 10.1038/35010115. Nature. 2000. PMID: 10801128

4

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus.

Dörner T, Putterman C. Dörner T, et al. Arthritis Res. 2001;3(4):197-9. doi: 10.1186/ar299. Epub 2001 Mar 20. Arthritis Res. 2001. PMID: 11438034 Free PMC article.

5

Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.

Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A. Day ES, et al. Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k. Biochemistry. 2005. PMID: 15697217

6

Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.

Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Marsters SA, et al. Curr Biol. 2000 Jun 29;10(13):785-8. doi: 10.1016/s0960-9822(00)00566-2. Curr Biol. 2000. PMID: 10898980 Free article.

7

An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML. Schiemann B, et al. Science. 2001 Sep 14;293(5537):2111-4. doi: 10.1126/science.1061964. Epub 2001 Aug 16. Science. 2001. PMID: 11509691

8

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM. Kayagaki N, et al. Immunity. 2002 Oct;17(4):515-24. doi: 10.1016/s1074-7613(02)00425-9. Immunity. 2002. PMID: 12387744 Free article.

9

B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.

Nardelli B, Moore PA, Li Y, Hilbert DM. Nardelli B, et al. Leuk Lymphoma. 2002 Jul;43(7):1367-73. doi: 10.1080/10428190290033297. Leuk Lymphoma. 2002. PMID: 12389615 Review.

10

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.

Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V, Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS. Roschke V, et al. J Immunol. 2002 Oct 15;169(8):4314-21. doi: 10.4049/jimmunol.169.8.4314. J Immunol. 2002. PMID: 12370363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year